Research Integrity Risk Index (RI²): A Critical Evaluation Review
DOI:
https://doi.org/10.46966/msjar.v6i3.302Abstract
Background: RI2 is a newly founded measure, designed to assess the research integrity in the world universities. This measure is based on two indicators; these are the published-research retraction rate and the rate of researches published in journals that have been delisted from Scopus and Web of Science indexes. The measure is characterized by its reliance on verifiable references including monitoring the number of retracted published studies, which enables the universities and other research relevant bodies to diagnose any research integrity concerns. This means that RI² is a mixed quantitative-qualitative measure. Purpose: This paper aims at evaluating RI² via analyzing its systematic methodology, data accuracy, transparency, and effectiveness. Method: The study was conducted through reviewing the available relevant literature, including the RI2 evaluation process mechanisms. Results: Although the approaches followed by the measure were qualitative quantitative, there are some criticisms that need to be solved to improve the performance of the measure. Conclusions: Caution is warranted, as research retraction rates can have different implications and may be indicative of high levels of monitoring and oversight rather than misconduct. Moreover, issues such as incomplete metadata and methodological decisions can influence results. Recommendations: It is argued that improving normalization methods and data quality would enhance RI²’s fairness and reliability.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dhurgham A. Abdulwahid, Alaa H. Abed

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















